Multi-target TMS for Schizophrenia Negative Symptoms
RecruitingNCT07559084Phase: NAStarted 2026-05-01
Summary
This randomized controlled trial (RCT) is the first to evaluate the efficacy and safety of a multi-target TMS protocol targeting the left dorsolateral prefrontal cortex (L-DLPFC), left inferior pariet
Eligibility
Sex
ALL
Min Age
16 Years
Max Age
45 Years
Locations
Shanghai Mental Health CenterShanghai, Shanghai Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07559084